Table 3.
Periodontal indices and MDA levels at baseline and three months upon therapy completion in groups with moderate and severe gingival inflammation (GI).
| GI Moderate (n = 14) | GI Severe (n = 16) | |
|---|---|---|
| PI—baseline | 1.08 ± 0.27 | 1.76 ± 0.11 a |
| PI—3 mo after therapy | 0.31 ± 0.10 b | 0.67 ± 0.35 b |
| GI—baseline | 1.37 ± 0.26 | 2.28 ± 0.21 a |
| GI—3 mo after therapy | 0.41 ± 0.20 b | 0.68 ± 0.52 b |
| PBI—baseline | 1.89 ± 0.39 | 2.01 ± 0.77 a |
| PBI—3 mo after therapy | 0.56 ± 0.27 b | 0.88 ± 0.53 b |
| PD (mm)—baseline | 2.88 ± 0.40 | 3.30 ± 0.57 a |
| PD (mm)—3 mo after therapy | 2.40 ± 0.31 b | 2.81 ± 0.49 b |
| CAL (mm)—baseline | 2.48 ± 0.78 | 2.96 ± 1.32 |
| CAL (mm)—3 mo after therapy | 1.69 ± 0.73 b | 1.91 ± 1.03 b |
| MDA-saliva (pmol/μL)—baseline |
2.42 ± 1.10 | 3.62 ± 1.22 a |
| MDA-saliva (pmol/μL)—3 mo after therapy |
1.83 ± 0.73 b | 2.50 ± 1.07 b |
| MDA-plasma (pmol/μL)—baseline |
0.45 ± 0.12 | 0.55 ± 0.13 a |
| MDA-plasma (pmol/μL)—3 mo after therapy |
0.43 ± 0.12 | 0.51 ± 0.09 |
a The difference between subgroups with moderate and severe inflammation was significant at baseline (p < 0.05). b Statistically significant difference compared with the baseline values (p < 0.05).